Thinking Out Loud: December 2024

Thinking Out Loud: December 2024

Even more Fearless in 2025 2024 was a year of transformation and momentum for us—a real steppingstone to EpiVax 2.0. We are grateful to our new CEO, Rich-Henry Schabowsky, for creating a work environment where innovation moves at a human pace. Because together, we...
Thinking Out Loud: November 2024

Thinking Out Loud: November 2024

Talking out loud to myself (and about 7000 friends) It’s the time of year for gratitude As we approach the season of gratitude, I would like to THANK YOU, our colleagues in the immunogenicity space, who are “Science Forward”....
Thinking Out Loud: October 2024

Thinking Out Loud: October 2024

October is Rocking! Off to Amsterdam and Stockholm EpiVax Sets the Standards for the Generic Drug Industry Ok . . .  that’s an over-the-top headline! But read the press release! It reflects our excitement about our new contract with...
Thinking Out Loud: September 2024

Thinking Out Loud: September 2024

September Falling Forward The Transition Suddenly, summer is over! No more long bike rides, afternoon sailing sessions, or dinners in the back yard. We have fall to look forward to and in New England, that means crisp days and colorful foliage. Fall also brings...